Clinical Research Directory
Browse clinical research sites, groups, and studies.
(De)Prescribing in Hospitalized Sarcopenic Geriatric Patients
Sponsor: Zuyderland Medisch Centrum
Summary
The goal of this clinical trial is to compare the effects of a deprescribing pharmacotherapy approach to the STOPP-START approach (usual care) in geriatric patients with sarcopenia and polypharmacy. The main question it aims to answer is the number and type of medication that can be stopped in this population without being restarted within 6 months. After inclusion a medication review is performed by a team consisting of the researcher, a geriatrician and a hospital pharmacist, according to the protocol within which the patient was randomised. Participants are follow up at appointments after 1, 3 and 6 months. At these appointments, questionnaires are administered about the quality of life and complications related to medication.
Official title: Medication (de)Prescribing in Hospitalized Geriatric Patients With Sarcopenia, Less is More
Key Details
Gender
All
Age Range
70 Years - Any
Study Type
INTERVENTIONAL
Enrollment
160
Start Date
2023-02-27
Completion Date
2027-08
Last Updated
2023-03-07
Healthy Volunteers
No
Conditions
Interventions
deprescribing pharmacotherapy approach (DPA)
A new way of medication review in patients with sarcopenia. This method is based on previous scientific research and is aimed at minimizing pharmacotherapy. The aim is to combat symptoms and complaints and to stop (preventive) medication as much as possible
STOPP-START deprescribing approach (SSA)
The usual care in the geriatric medicine in the Netherlands consisting of a medication review based on the STOPP-START criteria. These criteria have been combined in a protocol that describes when certain medication(groups) must be continued or discontinued for specific patient characteristics.